hrp0089p3-p210 | GH & IGFs P3 | ESPE2018

A Pilot Study for Comparing Efficacy and Safety of the CinnaTropin® to the Reference Recombinant Human GH in Children with Isolated GH Deficiency and Multiple Pituitary Hormone Deficiency

Razzaghy-Azar Maryam , Pourmotabbed Abdoreza , Heshmat Ramin , Rezaei Farhang

Background: CinnaTropin® (CinnaGen, Iran) is a recombinant human GH manufactured in Iran. Herein, we compared the efficacy and safety of the CinnaTropin® with the corresponding reference (Nordilet® Norditropin, Novo Nordisk, Denmark) in children with idiopathic GH deficiency (IGHD) and multiple pituitary hormone deficiency (MPHD).Methods: This was a randomized, open-label and cross-over study. Eligible pati...